CapitaLand Integrated Commercial Trust (CICT) Announces Major S\$3.85 Billion Acquisition of Paragon on Orchard Road

Key Highlights of the Announcement

• Proposed Acquisition: CICT has entered into a Sale and Purchase Agreement to acquire 100% of Paragon Trust and Orchard 290 Ltd, which together own Paragon—a premier freehold integrated retail, medical and office property on Orchard Road, Singapore—for an estimated S\$3,848 million, subject to completion adjustments.
• Strategic Asset: Paragon is a six-storey upscale retail mall with two medical and office towers, with a total net lettable area of approximately 714,900 sq ft (491,800 sq ft retail, 223,100 sq ft medical/office), and a gross floor area of 1,016,231 sq ft. The property boasts 100% committed occupancy as at 31 January 2026.
• Valuation: The agreed property value of S\$3,900 million is based on the average of two independent valuations (Knight Frank: S\$3,895 million; Cushman & Wakefield: S\$3,905 million), highlighting a tight pricing range and robust asset quality.
• Financing: The acquisition will be funded through a mix of debt, net proceeds from a new private placement (targeting at least S\$600 million), and proceeds from the upcoming sale of Asia Square Tower 2. If the sale of AST2 is delayed, a bridging loan will be used.
• Accretive Transaction: The acquisition is expected to be 2.1% distribution per unit (DPU) accretive on a pro forma basis for FY2025. Aggregate leverage post-transaction will be 39.2%, well below the 50% regulatory limit.
• Unitholder Approval Required: This is an interested person/party transaction due to Temasek Holdings’ (THPL) significant interest in both CICT and the vendors. An Extraordinary General Meeting (EGM) will be convened in Q2 or Q3 2026 to seek unitholder approval.

Details of the Proposed Acquisition

• Vendors: Cuscaden Peak Pte. Ltd., Cuscaden Peak Two Pte. Ltd., Times Properties Private Limited, and Paragon Trust Management Pte. Ltd.—all indirect subsidiaries of Temasek Holdings.
• Consideration Calculation: S\$3,900 million (property value) less S\$52 million (net liabilities of Paragon Trust and Orchard 290), subject to completion adjustments for actual net asset value at completion.
• Total Outlay: About S\$3,919 million, comprising purchase consideration, S\$39 million acquisition fee (paid in CICT units), and S\$32 million in related costs (including professional fees and stamp duty).
• Property Management: After completion, the property will be managed under CICT’s existing 2023 Master Property Management Agreement, ensuring operational alignment with the rest of CICT’s Singapore portfolio.

Strategic and Financial Rationale

• Rare Opportunity in Orchard Road: Freehold assets of Paragon’s quality and scale are seldom available. The property sits at the intersection of retail, medical, and hospitality clusters, adjacent to Mount Elizabeth Hospital, benefiting from resilient demand from both local shoppers and tourists.
• Defensive and Diversified Income: Paragon’s medical suites (over 80 tenants, with only ~2,000 such suites in Singapore) generate stable income backed by structural growth drivers like an ageing population and medical tourism. Retail occupancy has been maintained at or near 100% across market cycles.
• Potential Upside: CICT plans to explore asset enhancement initiatives post-acquisition. Preliminary studies suggest S\$300 million or more could be invested, with details subject to feasibility studies.
• Portfolio Impact: CICT’s retail exposure in Orchard Road will increase by 6.9%, further balancing the portfolio across Suburban, Downtown Core, and Orchard Road properties and solidifying CICT as the largest owner of private retail space in Singapore.
• Yield and DPU Accretion: The deal is accretive, with a 3.9% net yield (adjusted for FY2025 income and occupancy). Pro forma DPU for FY2025 rises from 11.58 cents to 11.83 cents, a 2.1% accretion. NAV per unit rises to S\$2.11.
• Leverage: Pro forma aggregate leverage is 39.2%, with flexibility for further portfolio optimisation. If AST2 is not divested, leverage would rise to 44.2%, still below regulatory limits.

Risks and Shareholder Considerations

• Interested Person Transaction: As the vendors are related to Temasek Holdings, which is a controlling unitholder of CICT and the ultimate holding company of the Manager, the acquisition is classified as an “interested person/party transaction.” Approval from independent unitholders is mandatory.
• Regulatory Approvals: Completion is subject to key conditions including IRAS confirming no stamp duty is payable on the transfer, and no compulsory acquisition or major damage to the property before completion. If IRAS approval is not obtained, CICT may choose not to proceed with the acquisition.
• Timing: EGM for unitholder approval is expected in Q2 or Q3 2026. Completion is targeted for Q3 2026, subject to all approvals and conditions being met.
• Market Sensitivity: As this is a significant, accretive, and strategic transaction with portfolio-wide implications, the news is highly price-sensitive and could materially impact CICT’s share price, especially considering the DPU accretion, enhanced portfolio quality, and long-term growth potential.
• Directors’ Interests: Some directors of the Manager are executives of CapitaLand and CLI, which are associated with Temasek Holdings. Collectively, directors hold 780,025 units. Temasek’s deemed interest as of the announcement date is 21.58% of total units.
• Independent Financial Adviser: Ernst & Young Corporate Finance Pte Ltd has been appointed to advise on the transaction’s fairness and to opine on whether it is not prejudicial to minority unitholder interests. Their opinion will be disclosed in the EGM circular.

What Should Shareholders Do?

• Review the EGM Circular: Before voting, shareholders should study the forthcoming EGM circular, which will include the Independent Financial Adviser’s opinion, full terms, and potential risks.
• Note the Accretive Nature: The acquisition is expected to immediately enhance DPU and NAV, strengthen CICT’s position in Singapore’s most sought-after retail precinct, and lower income concentration risk.
• Understand the Portfolio Impact: CICT will remain 95% Singapore-focused, with portfolio value increasing from S\$27.0 billion to S\$28.7 billion post-acquisition (excluding AST2), and a stronger tilt towards integrated developments.
• Monitor Upcoming Developments: Market may react to news of the EGM timing, the result of the IRAS stamp duty waiver request, and updates on the sale of Asia Square Tower 2.

Summary Table: Pro Forma Portfolio Metrics (Post-Acquisition and AST2 Divestment)

Next Steps

• EGM to be held in Q2 or Q3 2026 for unitholder approval.
• Completion is targeted for Q3 2026, conditional on regulatory and unitholder approvals.
• EGM circular with IFA opinion to be released in due course.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to read the official documents, circulars and seek professional advice before making any investment decisions. The information herein is based on company disclosures and may be subject to change. Past performance is not indicative of future results. Investments in REITs and securities are subject to market risks, including possible loss of principal. The reporter and publisher take no responsibility for decisions made based on this article.

View CapitaLandInvest Historical chart here